Prevalence of Monoclonal Gammopathy of Undetermined Significance

Kyle, Robert A., Therneau, Terry M., Rajkumar, S. Vincent, Larson, Dirk R., Plevak, Matthew F., Offord, Janice R., Dispenzieri, Angela, Katzmann, Jerry A., Melton, L. Joseph·2006·New England Journal of Medicine
DOI 10.1056/nejmoa054494

Cited by (1,000)

Items 301–400 of 1,000

  1. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis
    Felix Kleefeld, Elise Scherret, Fabian Knebel, Daniel Messroghli, Bettina Heidecker, Christoph Wetz, Imke Schatka, Gina Barzen, Carsten Tschöpe, Holger Amthauer et al. · 2022 · Amyloid
  2. Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance
    Yuxin Liu, Anna L. Parks · 2025 · JAMA Internal Medicine
  3. Effects of Aging on the Adaptive Immune Response to Respiratory Virus Infections
    Ross Bane Fulton, Steven M. Varga · 2009 · Aging Health
  4. Coexistence of Myeloproliferative Neoplasm and Plasma-Cell Dyscrasia
    Jyoti Dhar Malhotra, Marina Kremyanskaya, Emily M. Schorr, Ronald Hoffman, John O Mascarenhas · 2013 · Clinical Lymphoma Myeloma & Leukemia
  5. Neuropathy and monoclonal gammopathy
    Eduardo Nobile‐Orazio · 2013 · Handbook of clinical neurology
  6. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review
    Maira A. Castañeda‐Avila, Christine M. Ulbricht, Mara Meyer Epstein · 2021 · Annals of Hematology
  7. Mutational landscape reflects the biological continuum of plasma cell dyscrasias
    Andrea Rossi, Minna Voigtlaender, Snjezana Janjetovic, Benjamin Thiele, Malik Alawi, Manuela März, Anna Paula Brandt, Timon Hansen, Janina Radloff, Gerhard Schön et al. · 2017 · Blood Cancer Journal
  8. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist
    Antoine Sicard, Alexandre Karras, Jean Michel Goujon, Christophe Sirac, Sébastien Bender, D. Labatut, P Callard, Clémentine Sarkozy, Marie Essig, Philippe Vanhille et al. · 2014 · Nephrology Dialysis Transplantation
  9. C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome
    Isaac E. Lloyd, Alexander J. Gallan, Hunter K. Huston, Kalani L. Raphael, Dylan V. Miller, Monica Patricia Revelo, Mazdak A. Khalighi · 2016 · Clinical Kidney Journal
  10. Genomic landscape of multiple myeloma and its precursor conditions
    Alberge, Jean-Baptiste, Dutta, Ankit K., Poletti, Andrea, Coorens, Tim H. H., Lightbody, Elizabeth D., Toenges, Rosa, Loinaz, Xavi, Wallin, Sofia, Dunford, Andrew, Priebe, Oliver et al. · 2025 · Nature Genetics
  11. Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis
    Nicola Veronese, Claudio Luchini, Marco Solmi, Giuseppe Sergi, Enzo Manzato, Brendon Stubbs · 2017 · Journal of Bone and Mineral Metabolism
  12. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma
    Carolina Schinke, Pingping Qu, Syed Jafar Mehdi, Antje Hoering, Joshua Epstein, Sadie Johnson, Frits van Rhee, Maurizio Zangari, Sharmilan Thanendrarajan, Bart Barlogie et al. · 2018 · Clinical Cancer Research
  13. Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
    Vijay G. Ramakrishnan, Kevin Charles Miller, Elaine P Macon, Teresa K. Kimlinger, Jessica L. Haug, Sanjay Kumar, Wilson I. Gonsalves, S. Vincent Rajkumar, Shaji Kunnathu Kumar · 2019 · Haematologica
  14. Multiple myeloma-A painful disease of the bone marrow.
    Marta Díaz-DelCastillo, A. Chantry, M. Lawson, A. Heegaard · 2020 · Seminars in Cell and Developmental Biology
  15. Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
    Henrik Gregersen, Mette Nørgaard, Marianne Tang Severinsen, Malene Cramer Engebjerg, Paw Jensen, Henrik Toft Sørensen · 2010 · European Journal Of Haematology
  16. Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells
    Andrew J. Campbell, Linden Lyne, Philip J. Brown, Rosalind Launchbury, Paola A. Bignone, Jianxiang Chi, Giovanna Roncador, Charles Henderson Lawrie, Kevin C. Gatter, Rajko Kušec et al. · 2010 · British Journal of Haematology
  17. Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study
    Sigrún Þorsteinsdóttir, Sigrún H. Lund, Ebba K. Lindqvist, Maríanna Þórðardóttir, Gunnar Sigurðsson, Rene Costello, Debra Burton, Hlíf Steingrímsdóttir, Vilmundur G. Gudnason, Guðný Eiríksdóttir et al. · 2017 · Blood Advances
  18. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease
    Alícia Molina Andújar, Pau Robles, María Teresa Cibeira, Enrique Montagud‐Marrahí, Elena Guillén, Marc Xipell, Miquel Blasco, Esteban Poch, Laura Rosiñol, Joan Bladé et al. · 2020 · BMC Nephrology
  19. Impact of metformin on the progression of MGUS to multiple myeloma
    Ben Boursi, Ronac Mamtani, Yu‐Xiao Yang, Brendan M. Weiss · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
  20. Detection of Circulating Tumor Plasma Cells in Monoclonal Gammopathies: Methods, Pathogenic Role, and Clinical Implications
    Luzalba Sanoja-Flores, Juan A Flores-Montero, Martín Pérez‐Andrés, Noemí Puig, Alberto Órfão · 2020 · Cancers
  21. Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects
    Natasha Mupeta Kaweme, Geoffrey Joseph Changwe, Fuling Zhou · 2021 · Frontiers in Medicine
  22. Rebalancing the unbalanced aged immune system – A special focus on zinc
    Bastian Robinson Baarz, Lothar Rink · 2021 · Ageing Research Reviews
  23. The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile
    Raphael Elie Szalat, Gentiane Monsel, Wilfried Le Goff, Maxime Battistella, Djaouida Bengouffa, Marie‐Hélène Schlageter, Jean‐David Bouaziz, Bertrand Arnulf, Marguerite Vignon, Philippe Lesnik et al. · 2015 · Journal of the American Academy of Dermatology
  24. Long-Term Follow-Up of Patients with Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation
    Harris V K Naina, Samar Harris, Angela A. Dispenzieri, Fernando G. Cosio, Thomas Matthew Habermann, Mark D. Stegall, Patrick G. Dean, Mikel Prieto, Robert A. Kyle, S. Vincent Rajkumar et al. · 2012 · American Journal of Nephrology
  25. Novel Aspects Pertaining to the Relationship of Waldenström's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia
    Mary L. McMaster, Sigurdur Yngvi Kristinsson, Ingemar Turesson, Magnus Björkholm, Ola Landgren · 2009 · Clinical Lymphoma & Myeloma
  26. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease
    Michelle L. Mauermann · 2017 · Hematology/Oncology Clinics of North America
  27. Artifactual Laboratory Abnormalities in Patients with Paraproteinemia
    Vivek Roy · 2009 · Southern Medical Journal
  28. Towards a new age in the treatment of multiple myeloma
    Francesco Piazza, Carmela Gurrieri, Livio Trentin, Gianpietro Semenzato · 2007 · Annals of Hematology
  29. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients
    Tommaso Zà, Valerio De Stefano, Elena Rossi, Maria Teresa Petrucci, Alessandro Andriani, Luciana Annino, Giuseppe G. Cimino, Tommaso Caravita, Francesco Pisani, Angela Ciminello et al. · 2012 · British Journal of Haematology
  30. Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies
    Valentin Maisons, Anna Duval, Laurent Mesnard, Marie Frimat, Fádi Fakhouri, Steven Grangé, Aude Servais, Claire Cartery, Laurent Fauchier, Paul Coppo et al. · 2024 · Kidney International
  31. Neurologic aspects of plasma cell disorders
    Urszula Sobol, Patrick J. Stiff · 2013 · Handbook of clinical neurology
  32. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
    Ebba K. Lindqvist, Ola Landgren, Sigrún H. Lund, Ingemar Turesson, Malin L. Hultcrantz, Lynn R. Goldin, Magnus Björkholm, Sigurdur Yngvi Kristinsson · 2016 · Annals of Hematology
  33. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma
    Gaurav Goyal, S. Vincent Rajkumar, Martha Q. Lacy, Morie Abraham Gertz, Francis K. Buadi, Angela A. Dispenzieri, Yi L. Hwa, Amie L Fonder, Miriam Hobbs, Suzanne R. Hayman et al. · 2019 · Leukemia
  34. Mesenchymal stromal cell senescence in haematological malignancies
    Natalya Plakhova, Vasilios Panagopoulos, Kate Vandyke, Andrew C.W. Zannettino, Krzysztof Marek Mrozik · 2023 · Cancer and Metastasis Reviews
  35. Renal amyloidosis: a new time for a complete diagnosis
    Valkercyo A. Feitosa, Precil Diego Miranda de Menezes Neves, Lectícia Jorge, Irene L. Noronha, Luiz Fernando Onuchic² · 2022 · Brazilian Journal of Medical and Biological Research
  36. New horizons in our understanding of precursor multiple myeloma and early interception
    David M. Cordas dos Santos, Rosa Toenges, Luca Bertamini, Jean-Baptiste Alberge, Irene M. Ghobrial · 2024 · Nature reviews. Cancer
  37. Clinical features in VEXAS syndrome: a systematic review
    Adam Al‐Hakim, Scott Goldberg, Ségolène Gaillard, Maël Heiblig, David B. Beck, Sinisa Savic · 2025 · Lara D. Veeken
  38. Monoclonal gammopathy of undetermined significance
    Rajkumar, S. Vincent, Kumar, Shaji · 2025 · New England Journal of Medicine
  39. Increasing Rate of Hospital Admissions in Patients With Amyloidosis (from the National Inpatient Sample)
    Brett Wesley Sperry, Ibrahim M. Saeed, Shahzad Raza, Kevin F. Kennedy, Mazen A Hanna, John A. Spertus · 2019 · The American Journal of Cardiology
  40. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
    Geffen Kleinstern, Dirk R. Larson, Cristine Allmer, Aaron D. Norman, Grace Muntifering, Jason P. Sinnwell, Alissa Visram, S. Vincent Rajkumar, Angela A. Dispenzieri, Robert A. Kyle et al. · 2022 · Blood Cancer Journal
  41. Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal
    Rafael Ríos, Bruno Paiva, Juan José Lahuerta, Joaquín Martínez‐López, Rafael F. Duarte · 2022 · Cancers
  42. Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (Review)
    Alessandro Martino · 2011 · International Journal of Oncology
  43. Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types
    Sarah R. Amend, William Cody Wilson, Liang Chu, Lan Lu, Pengyuan Liu, Daniel Serie, Xinming Su, Yalin Xu, Dingyan Wang, Anthony O. Gramolini et al. · 2015 · PLoS ONE
  44. Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: New Insights into Pathophysiology and Epidemiology
    Ola Landgren · 2010 · Hematology
  45. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients
    Xinxin Cao, Qi Meng, Yueying Mao, Wei Su, Jun‐feng Zhen, Kaini Shen, Chunlan Zhang, Xufei Huang, Minghui Duan, Wei Zhang et al. · 2016 · Leukemia Research
  46. Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population‐based cancer registries, 1996–2003
    Masako Iwanaga, Chun‐Ju Chiang, Midori Soda, Mei‐Shu Lai, Ya‐Wen Yang, Yasushi Miyazaki, Keitaro Matsuo, Tomohiro Matsuda, Tomotaka Sobue · 2013 · International Journal of Cancer
  47. Can Whole-body Low-dose Multidetector CT Exclude the Presence of Myeloma Bone Disease in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)?
    Daniel Spira, Katja Christina Weisel, Harald Brodoefel, Maximilian Schulze, Sascha Kaufmann, Marius Horger · 2011 · Academic Radiology
  48. Monoclonal gammopathy of undetermined significance: a new proposal of workup
    Silvia Mangiacavalli, Federica Cocito, Lara Pochintesta, Cristiana Pascutto, Virginia Valeria Ferretti, Marzia Varettoni, Patrizia Zappasodi, Alessandra Pompa, Benedetta Landini, Mario Cazzola et al. · 2013 · European Journal Of Haematology
  49. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma
    Sham Mailankody, Esther Mena, Constance M. Yuan, Arun Balakumaran, W. Michael Kuehl, Ola Landgren · 2010 · Leukemia & lymphoma/Leukemia and lymphoma
  50. Erratum: The Hematologic Definition of Monoclonal Gammopathy of Undetermined Significance in Relation to Paraproteinemic Keratopathy (An American Ophthalmological Society Thesis).
    Walter Lisch, Joanna Wasielica‐Poslednik, Tero Kivelä, Ursula M. Schlötzer-Schrehardt, Jens Martin Rohrbach, Walter Sekundo, Uwe Pleyer, Christina Lisch, Alexander Desuki, Heidi Rossmann et al. · 2016 · PubMed Central
  51. Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Robert A. Kyle, S. Vincent Rajkumar · 2007 · Hematology/Oncology Clinics of North America
  52. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
    Aðalbjörg Ýr Sigurbergsdóttir, Þorvarður Jón Löve, Sigurdur Yngvi Kristinsson · 2022 · Frontiers in Immunology
  53. Elevation of Serum Immunoglobulin Free Light Chains During the Preclinical Period of Rheumatoid Arthritis
    Xiaoli Deng, Cynthia S. Crowson, S. Vincent Rajkumar, Angela A. Dispenzieri, Dirk R. Larson, Terry M. Therneau, Eric L. Matteson, Robert A. Kyle, Jerry A. Katzmann, Sherine E. Gabriel et al. · 2015 · The Journal of Rheumatology
  54. Dietary intake is associated with risk of multiple myeloma and its precursor disease
    Maríanna Þórðardóttir, Ebba K. Lindqvist, Sigrún H. Lund, Rene Costello, Debra Burton, Laufey Steingrímsdóttir, Neha Korde, Sham Mailankody, Guðný Eiríksdóttir, Lenore J. Launer et al. · 2018 · PLoS ONE
  55. Bringing mass spectrometry into the care of patients with multiple myeloma
    David L. Murray · 2022 · International Journal of Hematology
  56. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma
    Sergio A. Giralt, Stephen R.A. Jolles, Tessa C. C. Kerre, Hillard Michael Lazarus, Syed Shahzad Mustafa, Genovefa A. Papanicolaou, Roberto Ria, Donald Cuong Vinh, John R. Wingard · 2023 · Clinical Lymphoma Myeloma & Leukemia
  57. Monoclonal gammopathy and neuropathy
    Pierre Lozeron, David Adams · 2007 · Current Opinion in Neurology
  58. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD
    James P. Ritchie, Lakhvir Kaur Assi, Anne Burmeister, Richard A. Hoefield, Paul Cockwell, Philip A. Kalra · 2015 · Clinical Journal of the American Society of Nephrology
  59. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review
    Jasneet Kaur, Sai Sudha Valisekka, Maha Hameed, Pushyami Satya Bandi, Samyukta Varma, Chibuzor Joseph Onwughalu, Hany Ibrahim, Himani Mongia · 2023 · Clinical Lymphoma Myeloma & Leukemia
  60. Nuclear Remodeling as a Mechanism for Genomic Instability in Cancer
    Macoura Gadji, Rhea U. Vallente, Ludger Klewes, Christiaan H. Righolt, Landon Wark, Narisorn Kongruttanachok, Hans Knecht, Sabine Mai · 2011 · Advances in cancer research
  61. Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism
    Rodrigo Carlini Fernando, Diego R. Mazzotti, Hatylas F. Z de Azevedo, Alex Freire Sandes, Edgar Gil Rizzatti, Mariana Bleker de Oliveira, Veruska Lia Fook Alves, Angela Isabel Pereira Eugênio, Fabrício de Carvalho, Maria Aparecida Dalboni et al. · 2019 · Scientific Reports
  62. Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis
    Kirk Lachlan Morris, Jill R. Tate, Devinder Singh Gill, Glen Kennedy, Jeremy Wellwood, Paula V. Marlton, Robert J Bird, Anthony K. Mills, Peter N. Mollee · 2007 · Internal Medicine Journal
  63. Prevalence of monoclonal gammopathy of undetermined significance in Thailand
    Phandee Watanaboonyongcharoen, Thanyaphong Na Nakorn, Ponlapat Rojnuckarin, Panisinee Lawasut, Tanin Intragumtornchai · 2012 · International Journal of Hematology
  64. Long‐term follow‐up of a population based cohort with monoclonal proteinaemia
    C. G. Schaar, Saskia le Cessie, Simone Snijder, Paul Franck, Pierre Wijermans, Cisca Ong, Hanneke C. Kluin‐Nelemans · 2008 · British Journal of Haematology
  65. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies
    Larissa S. Higgins, Ronald S. Go, David Dingli, Shaji Kunnathu Kumar, S. Vincent Rajkumar, Angela A. Dispenzieri, Francis K. Buadi, Martha Q. Lacy, John Anthony Lust, Prashant Kapoor et al. · 2016 · Clinical Lymphoma Myeloma & Leukemia
  66. Recent advances in multiple myeloma: a Korean perspective
    Junshik Hong, Jae Hoon Lee · 2016 · The Korean Journal of Internal Medicine
  67. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance
    Alyssa Clay‐Gilmour, Michelle A.T. Hildebrandt, Elizabeth E. Brown, Jonathan N. Hofmann, John Joseph Spinelli, Graham G. Giles, Wendy Cozen, Parveen Bhatti, Xifeng Wu, Rosalie G. Waller et al. · 2020 · Blood Advances
  68. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
    Vasiliki Bistola, John Parissis, Emmanouil G Foukarakis, Pipitsa N. Valsamaki, Aris Anastasakis, Georgios Koutsis, Georgios K. Efthimiadis, Efstathios Kastritis · 2021 · Heart Failure Reviews
  69. Acquired von Willebrand Syndrome
    Arielle L. Langer, Nathan T. Connell · 2021 · Hematology/Oncology Clinics of North America
  70. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS
    Zi-hao Yong, Xiao-juan Yu, Jing-xia Liu, Fu-de Zhou, Su-xia Wang, Ming-hui Zhao · 2022 · Clinical Journal of the American Society of Nephrology
  71. Granulocyte transfusion therapy: randomization after all?
    Agata Drewniak, Taco Willem Kuijpers · 2009 · Haematologica
  72. Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia
    J M Vallat, Laurent Magy, Laurence Richard, Franck G. Sturtz, Philippe Couratier · 2007 · Micron
  73. IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study
    Matthew Ahlskog, Neeraj Kumar, Michelle L. Mauermann, Christopher J. Klein · 2012 · Parkinsonism & Related Disorders
  74. The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions
    Catherine Atkin, Vinay Reddy‐Kolanu, Mark Trehane Drayson, Elizabeth Sapey, Alex G Richter · 2020 · British Journal of Haematology
  75. Paraproteinemic neuropathy
    Saša Živković, David Lacomis, Suzanne Lentzsch · 2009 · Leukemia & lymphoma/Leukemia and lymphoma
  76. Cold agglutinin disease.
    Morie Abraham Gertz · 2006 · PubMed
  77. Lifetime Pesticide Use and Monoclonal Gammopathy of Undetermined Significance in a Prospective Cohort of Male Farmers
    Jonathan N. Hofmann, Laura E. Beane Freeman, Kazunori Murata, Gabriella Andreotti, Joseph J. Shearer, Katie L. Thoren, Lakshmi V. Ramanathan, Christine Gibson Parks, Stella Koutros, Catherine Chase Lerro et al. · 2021 · Environmental Health Perspectives
  78. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
    Pang Li, S. Vincent Rajkumar, Prashant Kapoor, Francis K. Buadi, Angela A. Dispenzieri, Morie Abraham Gertz, Martha Q. Lacy, Robert A. Kyle, Shaji Kunnathu Kumar · 2021 · Blood Cancer Journal
  79. Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis
    Louis Bonnefous, Mounira Kharoubi, Mélanie Bézard, Silvia Oghina, Fabien Le Bras, Elsa Poullot, Valérie Molinier‐Frenkel, Pascale Fanen, Jean‐François Deux, Vincent Audard et al. · 2021 · Journal of the American College of Cardiology
  80. Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events
    Ola Landgren · 2021 · Hematology
  81. Smoldering Multiple Myeloma
    S. Vincent Rajkumar, Peter Leif Bergsagel, Shaji Kunnathu Kumar · 2023 · Hematology/Oncology Clinics of North America
  82. MGUS prevalence in an ethnically Chinese population in Hong Kong
    Shengyang Peter Wu, Alex R. Minter, Rene Costello, Adriana Zingone, Cheuk Kwong Lee, Wing-Yan Au, Ola Landgren · 2013 · Blood
  83. Chronic Demyelinating Polyneuropathies
    Jeffrey A. Allen · 2017 · CONTINUUM Lifelong Learning in Neurology
  84. The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
    Mina Ali, Ram Ajore, Anna-Karin Wihlborg, Abhishek Niroula, Bhairavi Swaminathan, Ellinor Johnsson, Owen Stephens, Gareth John Morgan, Tobias Meißner, Ingemar Turesson et al. · 2018 · Nature Communications
  85. Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases
    Ola Landgren, Robert A. Kyle · 2007 · British Journal of Haematology
  86. Multiple myeloma after kidney transplantation
    Sami Safadi, Angela A. Dispenzieri, Hatem Amer, Morie Abraham Gertz, S. Vincent Rajkumar, Suzanne R. Hayman, Martha Q. Lacy, Nelson Leung · 2014 · Clinical Transplantation
  87. Reappraisal of risk factors for monoclonal gammopathy of undetermined significance
    Ben Boursi, Brendan M. Weiss, Kevin Haynes, Ronac Mamtani, Yu‐Xiao Yang · 2016 · American Journal of Hematology
  88. Gammapatías monoclonales de significado renal
    Fernando Caravaca‐Fontán, Eduardo Gutiérrez, Ramón Delgado Lillo, Manuel Praga · 2017 · Nefrología
  89. Diagnostik und Therapie der kardialen Amyloidose
    Ali Yılmaz, Johann K Bauersachs, Ingrid Kindermann, Karin Klingel, Fabian Knebel, Benjamin Meder, Caroline Morbach, Eike C. Nagel, Eric Schulze‐Bahr, Fabian aus dem Siepen et al. · 2019 · Der Kardiologe
  90. Histopathologic and Clinical Features in Patients with Diabetes and Kidney Disease
    Sarah F. Sanghavi, Travis Roark, Leila R. Zelnick, Behzad Najafian, Nicole K. Andeen, Charles E. Alpers, Raimund H. Pichler, Ernest Ayers, Ian H. de Boer · 2020 · Kidney360
  91. A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity
    Matteo Da Vià, Bachisio Ziccheddu, Akihiro Maeda, Filippo Bagnoli, Giulia Perrone, Niccolò Bolli · 2020 · HemaSphere
  92. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
    Artem Oganesyan, Andrew Gregory, Florent Malard, Nerses Ghahramanyan, Mohamad Mohty, Dickran Gano Kazandjian, Arsène MEKINIAN, Yervand K. Hakobyan · 2022 · Frontiers in Immunology
  93. Inherited predisposition to multiple myeloma
    Divya T. Koura, Amelia A. Langston · 2013 · Therapeutic Advances in Hematology
  94. Immunophenotypic studies of monoclonal gammopathy of undetermined significance
    Horatiu Olteanu, Huan‐You Wang, Weina Chen, Robert W. McKenna, Nitin J. Karandikar · 2008 · BMC Clinical Pathology
  95. Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case–control study
    Lotte Vlam, Sanne Piepers, Nadia A. Sutedja, Bart Casper Jacobs, Anne P. Tio‐Gillen, Marloes Stam, Hessel Franssen, Jan Herman Veldink, Elisabeth A. Cats, Nicolette C. Notermans et al. · 2014 · Journal of Neurology
  96. Management of the elderly patient with AL amyloidosis.
    M. Nuvolone, P. Milani, G. Palladini, G. Merlini · 2018 · European journal of internal medicine
  97. Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
    Aleksander Salomon‐Perzyński, Krzysztof Jamroziak, Eliza Głodkowska‐Mrówka · 2021 · Diagnostics
  98. The tumor suppression theory of aging
    Alexander Martin Wolf · 2021 · Mechanisms of Ageing and Development
  99. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population
    Hyun‐Kyung Park, K.‐R. Lee, Young Jin Kim, Han‐Ik Cho, Jung Eun Kim, Ki Woong Kim, Yu Jung Kim, Keun‐Wook Lee, Jee Hyun Kim, Soo‐Mee Bang et al. · 2011 · American Journal of Hematology
  100. The significance of monoclonal gammopathy of undetermined significance
    Robert A. Kyle, Shaji Kunnathu Kumar · 2009 · Haematologica